Family Medicine Doctors in Aberdeen Proving Ground, MD Accepting Medicare

4 Family Medicine doctors found. Showing 1 - 4

Carol G Hooper, M.D. Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2501 Oakington St, Aberdeen Proving Ground, MD 21005 Phone: 140-278-1727

Rajesh Devkota, FNP Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 6455 Machine St, Aberdeen Proving Ground, MD 21005 Phone: 410-278-7487

Joseph V. Perugino, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2501 Oakington St, Aberdeen Proving Ground, MD 21005 Phone: 410-278-1813

Melinda Marilyn Reed-linton, MD Family Medicine Medicare: Not Enrolled in Medicare Practice Location: 2501 Oakington St, Aberdeen Proving Ground, MD 21005 Phone: 410-278-1813

News Archive

Widely available drug could reduce deaths in traumatic brain injury patients, major study shows

A low cost and widely available drug could reduce deaths in traumatic brain injury patients by as much as 20%, depending on the severity of injury, according to a major study published in The Lancet.

Beta arrestins found to generate new proteins

Duke University Medical Center researchers have recently discovered that a crucial communications pathway in cells not only stops cells from making proteins, it also makes them go. The team was able to define the way in which proteins called beta arrestins (for their role in stopping signals) also turn on pathways that ultimately lead to the production of new proteins in virtually all tissues in the body.

New maintenance treatment for AML shows strong benefit for patients

Patients with acute myeloid leukemia (AML), the most common form of acute leukemia in adults, that has gone into remission following initial chemotherapy remain in remission longer and have improved overall survival when they are given a pill form of the cancer drug azacitidine as a maintenance treatment, according to a randomized, international phase 3 clinical trial for which Weill Cornell Medicine and NewYork-Presbyterian are trial sites.

Light Sciences Oncology announces Phase 2 trial of Aptocine in Benign Prostatic Hyperplasia

Light Sciences Oncology, Inc. (LSO) today announced the treatment of the first patients in a Phase 2 clinical trial of its innovative targeted drug treatment Aptocine(TM) (talaporfin sodium) in Benign Prostatic Hyperplasia (BPH). The Phase 2 trial expands the Aptocine BPH development program on the basis of a Phase 1 study at escalating light doses. In the open-label Phase 2 trial, Aptocine is being tested for safety and efficacy in 40 patients with lower urinary tract symptoms (LUTS) due to BPH. Aptocine is also in two Phase 3 clinical trials for solid tumors in the liver as well as preclinical development for prostate cancer.

Female sex hormones help women survive after trauma

Women who have been severely injured are 14 percent more likely to survive than similarly injured men, according to a new Johns Hopkins study, a difference researchers believe may be due to the negative impact of male sex hormones on a traumatized immune system.

Read more Medical News

› Verified 1 days ago